Hispidulin Enhances Temozolomide (TMZ)-Induced Cytotoxicity against Malignant Glioma Cells In Vitro by Inhibiting Autophagy

Temozolomide (TMZ), an oral alkylating agent, is the widely used first-line chemotherapeutic reagent for glioma in clinical practice. However, TMZ-induced autophagy is another cellular process favoring glioma cell survival. This study aimed to explore whether hispidulin can facilitate TMZ-induced ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhihua, Zhu, Guofeng, Sheng, Chunpeng, Lei, Jianwei, Song, Sihui, Zhu, Jianming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256375/
https://www.ncbi.nlm.nih.gov/pubmed/35800695
http://dx.doi.org/10.1155/2022/5266770

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9256375/
https://www.ncbi.nlm.nih.gov/pubmed/35800695
http://dx.doi.org/10.1155/2022/5266770

Ejemplares similares